398 related articles for article (PubMed ID: 23246118)
1. A novel cyclosporine a drug-delivery system for prevention of human corneal rejection after high-risk keratoplasty: a clinical study.
Shi W; Chen M; Xie L; Liu M; Gao H; Wang T; Wu X; Zhao J
Ophthalmology; 2013 Apr; 120(4):695-702. PubMed ID: 23246118
[TBL] [Abstract][Full Text] [Related]
2. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant].
Shi W; Xie L; Wang S
Zhonghua Yan Ke Za Zhi; 2002 Aug; 38(8):502-5. PubMed ID: 12410993
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine a drug-delivery system for high-risk penetrating keratoplasty: Stabilizing the intraocular immune microenvironment.
Zhang T; Li Z; Liu T; Li S; Gao H; Wei C; Shi W
PLoS One; 2018; 13(5):e0196571. PubMed ID: 29734357
[TBL] [Abstract][Full Text] [Related]
4. Experimental study on the effect of cyclosporine A drug delivery system implanted in anterior chamber on high-risk corneal graft rejection.
Xie L; Shi W; Wang Z; Liu Z
Zhonghua Yan Ke Za Zhi; 2002 Jul; 38(7):422-5. PubMed ID: 12411004
[TBL] [Abstract][Full Text] [Related]
5. [Sustained rapamycin drug delivery system in prevention of high risk corneal allograft rejection and neovascularization in rabbits].
Gao H; Shi WY; Xie LX; Wang SG
Zhonghua Yan Ke Za Zhi; 2006 Jan; 42(1):6-11. PubMed ID: 16638273
[TBL] [Abstract][Full Text] [Related]
6. Predicted long-term outcome of corneal transplantation.
Borderie VM; Boëlle PY; Touzeau O; Allouch C; Boutboul S; Laroche L
Ophthalmology; 2009 Dec; 116(12):2354-60. PubMed ID: 19815285
[TBL] [Abstract][Full Text] [Related]
7. Long-term comparison of full-bed deep lamellar keratoplasty with penetrating keratoplasty in treating corneal leucoma caused by herpes simplex keratitis.
Wu SQ; Zhou P; Zhang B; Qiu WY; Yao YF
Am J Ophthalmol; 2012 Feb; 153(2):291-299.e2. PubMed ID: 21996306
[TBL] [Abstract][Full Text] [Related]
8. Ten-year postoperative results of penetrating keratoplasty.
Ing JJ; Ing HH; Nelson LR; Hodge DO; Bourne WM
Ophthalmology; 1998 Oct; 105(10):1855-65. PubMed ID: 9787355
[TBL] [Abstract][Full Text] [Related]
9. Deep anterior lamellar keratoplasty using acellular corneal tissue for prevention of allograft rejection in high-risk corneas.
Li J; Yu L; Deng Z; Wang L; Sun L; Ma H; Chen W
Am J Ophthalmol; 2011 Nov; 152(5):762-70.e3. PubMed ID: 21803324
[TBL] [Abstract][Full Text] [Related]
10. Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits.
Shi W; Gao H; Xie L; Wang S
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3339-44. PubMed ID: 16877400
[TBL] [Abstract][Full Text] [Related]
11. Graft rejection after Descemet's stripping automated endothelial keratoplasty: graft survival and endothelial cell loss.
Li JY; Terry MA; Goshe J; Shamie N; Davis-Boozer D
Ophthalmology; 2012 Jan; 119(1):90-4. PubMed ID: 22115709
[TBL] [Abstract][Full Text] [Related]
12. Large-diameter penetrating keratoplasty: indications and outcomes.
Skeens HM; Holland EJ
Cornea; 2010 Mar; 29(3):296-301. PubMed ID: 20118782
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine a drug-delivery system for high-risk keratoplasty.
Hong J; Liu Z; Sun X; Xu J
Ophthalmology; 2013 Sep; 120(9):e65-6. PubMed ID: 24001545
[No Abstract] [Full Text] [Related]
14. Initial endothelial cell density and chronic endothelial cell loss rate in corneal transplants with late endothelial failure.
Nishimura JK; Hodge DO; Bourne WM
Ophthalmology; 1999 Oct; 106(10):1962-5. PubMed ID: 10519593
[TBL] [Abstract][Full Text] [Related]
15. Intracameral cyclosporine drug delivery system in high-risk keratoplasty.
Galvis V; Tello A; Carreño NI; Revelo ML
Ophthalmology; 2013 Sep; 120(9):e64-5. PubMed ID: 24001543
[No Abstract] [Full Text] [Related]
16. Risk factors for corneal allograft rejection: intermediate results of a prospective normal-risk keratoplasty study.
Küchle M; Cursiefen C; Nguyen NX; Langenbucher A; Seitz B; Wenkel H; Martus P; Naumann GO
Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):580-4. PubMed ID: 12136292
[TBL] [Abstract][Full Text] [Related]
17. [Implantation of FK506 drug delivery system into the anterior chamber for inhibiting corneal rejection in high risk rabbit corneal allograft].
Shi WY; Liu T; Xie LX; Wang SG
Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):299-304. PubMed ID: 16762204
[TBL] [Abstract][Full Text] [Related]
18. Long-term changes in corneal endothelial cell density after repeat penetrating keratoplasty in eyes with endothelial decompensation.
Hayashi K; Kondo H; Maeno A; Takimoto M
Cornea; 2013 Jul; 32(7):1019-25. PubMed ID: 23328699
[TBL] [Abstract][Full Text] [Related]
19. Comparison of penetrating keratoplasty and deep lamellar keratoplasty for macular corneal dystrophy and risk factors of recurrence.
Cheng J; Qi X; Zhao J; Zhai H; Xie L
Ophthalmology; 2013 Jan; 120(1):34-9. PubMed ID: 23017278
[TBL] [Abstract][Full Text] [Related]
20. [Regression analysis of corneal endothelium after nonmechanical penetrating keratoplasty].
Langenbucher A; Nguyen NX; Kus MM; Blüthner K; Küchle M; Seitz B
Klin Monbl Augenheilkd; 2000 Jun; 216(6):393-9; discussion 400. PubMed ID: 10919119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
